Declaring monetary value and units sold under Canada's Access to Medicines Regime

Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever is later, the pharmaceutical company must complete and submit to the patent holder and the Commissioner of Patents a "Solemn or Statutory Declaration Under Paragraph 21.16(1)(b) of the Patent Act".

Publisher

Health Canada

Resources

2

Catalogue metadata updated

2020-09-17